1. J Thromb Haemost. 2005 Apr;3(4):797-8. doi: 10.1111/j.1538-7836.2005.01243.x.

Evaluation of the von Willebrand factor Y1584C polymorphism as a potential risk 
factor for bleeding in patients receiving anticoagulant treatment with vitamin K 
antagonists.

Tjernberg P, Van Der Heijden JF, Eikenboom JC, Reitsma PH.

DOI: 10.1111/j.1538-7836.2005.01243.x
PMID: 15842375 [Indexed for MEDLINE]